Adial Pharmaceuticals
Manufacturing · Virginia, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
4870 Sadler Rd Ste 300, Glen Allen, Virg...Phone Number
(804) 487-8196Website
www.adial.comRevenue
-Stock Symbol
ADILIndustry
About Adial Pharmaceuticals
Adial Pharmaceuticals Org Chart
Is Adial Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Adial Pharmaceuticals has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Adial Pharmaceuticals launches new products
Earning: See what the market has to say on Adial Pharmaceuticals recently announced quarterly report
Check out if Adial Pharmaceuticals is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Adial Pharmaceuticals
Website visits: Recent activity has been detected on your website
Click to see if Adial Pharmaceuticals had a recent Job posting/layoffs
Check if Adial Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Adial Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Reach out to Masked Content who joined Adial Pharmaceuticals as Masked Content
Find more new buyers
Company Profile Activity
Activity Insights
Adial Pharmaceuticals is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Adial Pharmaceuticals is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Adial Pharmaceuticals.
Adial Pharmaceuticals Tech Stack
A closer look at the technologies used by Adial Pharmaceuticals
Most Recent Scoops
Adial Pharmaceuticals News & Media
Adial Pharmaceuticals Reports 2026 Second Quarter Financial Results and Provides Business Update
Completed acquisition of Azora Therapeutics, adding AT177, a fully synthetic, oral, colon-targeted aryl hydrocarbon receptor (“Ahr”) agonist in development for ulcerative colitis, to its pipelineAdial Pharmaceuticals Expands Executive Leadership Team and Closes PIPE Financing
GLEN ALLEN, Va., June 16, 2026 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (Nasdaq: ADIL) (“Adial” or the “Company”) today announced that the Company’s Compensation Committee and Board of Directors granted Matthew Davidson and Julie Saiki, the Company’s newly appointed chief development officer and executive vice president of strategy, respectively, restricted stock units and stock options to purchase Company common stock as an inducement to them becoming employees of the Company in connectiAdial Pharmaceuticals Acquires Azora and Raises $26.8M PIPE, With More on Milestones
Adial Pharmaceuticals completed a stock-for-stock acquisition of Azora Therapeutics, issuing common and preferred shares that will leave former Azora holders with roughly 86.9% of the combined company on a fully diluted basis prior to the financing and note exchange. Concurrently, Adial secured $26…
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Adial Pharmaceuticals
Adial Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the development of treatments for addictions.... Read More
